The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

Patients with psoriasis without musculoskeletal involvement are 2.5 times more likely to have synovitis on imaging than control patients.

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.

The prevalence of drinking alcohol in the US has declined in recent years while belief that drinking is unhealthy has increased.